Servier Symphogen
Oncology antibody drug development
- B2B
About Servier Symphogen
Researching, discovering, and developing highly differentiated antibodies for cancer treatment, focusing on oncology and immune-oncology. Aiming for novel combination or stand-alone therapies.
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- Ballerup, Denmark
- Founded
- 2000
- Revenue
- $18.6M – $147MTamtam estimate
- Website
- symphogen.com
- linkedin.com/company/symphogen
Servier Symphogen at a glance
Servier Symphogen is a B2B company in the Biotechnology Research industry, headquartered in Ballerup, Denmark.
Servier Symphogen was founded in 2000.
Servier Symphogen has 51–250 employees.
Servier Symphogen's revenue is $18.6M – $147M (Tamtam estimate).
Selling to companies like Servier Symphogen?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies